GSK said the Food and Drug Administration approved Blujepa as an oral treatment for uncomplicated urogenital gonorrhea.

Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

At the San Antonio Breast Cancer Symposium (SABCS), a large retrospective analysis of U.S. electronic health records compared outcomes for patients with HER2-positive metastatic breast cancer who ...

Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...

In a randomized clinical trial, researchers compared the effect of single vs multiple treatment alternatives on care decisions.

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

Tai chi is an effective alternative approach for the long-term management of chronic insomnia in middle-aged and older adults.

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms ...

Add blood plasma replacement to the list of things a well-heeled New Yorker can do with $10,000 and a couple of hours to spare in Midtown Manhattan. The new-age treatment is one of the more expensive ...